DEA issues interim final rule implementing 2018 Farm Bill

In the prepublication version of today’s Federal Register, the U.S. Drug Enforcement Agency (DEA) issued an interim final rule (IFR) implementing conforming changes to DEA’s regulations as a result of the Agricultural Improvement Act of 2018 (i.e., the 2018 Farm Bill).

Importantly, DEA states that the interim final rule is intended to conform DEA’s regulations to the 2018 Farm Bill and does not create any additional regulatory requirements. Specifically, the interim final rule:

  1. Modifies DEA’s regulation defining tetrahydrocannabinols (THC) to exclude any material, compound, mixture, or preparation that falls within the definition of “hemp;

  2. Removes from Schedule V drug products in finished dosage formulations that have been approved by FDA that contains cannabidiol (CBD);

  3. Removes import and export controls over drug products in finished dosage formulations that have been approved by FDA that contains CBD; and

  4. Modifies DEA’s regulation defining “marihuana extracts” to clarify this definition only encompasses extracts containing greater than 0.3% THC.

DEA acknowledges that the 2018 Farm Bill did not modify the status of synthetic THC under the Controlled Substances Act, and that for synthetic THC, the THC concentration is not a determining factor of the control status. Rather, DEA states that all synthetically derived THC remains a Schedule I controlled substance.

Next steps

The interim final rule will become immediately effective upon official publication in the Federal Register. There will be a 60 day comment period.

 

Authored by Lynn Mehler and Sam Dietle

Contacts
Lynn Mehler
Partner
Washington, D.C.
Sally Gu
Senior Associate
Washington, D.C.

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2024 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.